Cisplatin tace
WebA total of 118 HCC patients treated with TACE were selected from April 2013 to November 2015. T1-weighted imaging (T1WI)/T2-weighted imaging (T2WI), DWI, and PWI were performed on all patients before and after TACE. Efficacy was evaluated according to modified Response Evaluation Criteria in Solid Tumors 1.1. WebJan 4, 2011 · In TACE after hepatic arterial infusion of cisplatin, the dose of cisplatin per patient ranged from 30 to 100 mg (average 87 ± 19 mg). Tumor Response Early tumor response was assessed by imaging outcomes at 1- to 3-month follow-up after initial …
Cisplatin tace
Did you know?
WebWhat is TACE? Transarterial chemoembolization or TACE combines the local delivery of chemotherapy with a procedure called embolization to treat cancer, most often of the liver. It is a non-surgical and minimally invasive … WebPurpose: The purpose of this retrospective study was to investigate the efficacy of transarterial chemoembolization (TACE) using cisplatin as a second-line treatment for advanced hepatocellular carcinoma (HCC) unresponsive to TACE using epirubicin …
WebAug 31, 2024 · Drug: Cisplatin. Phase 2. Detailed Description: Transcatheter arterial chemoembolization (TACE) has been playing an important role in the treatment algorithm for patients with multifocal or large intrahepatic lesions not eligible for surgical resection, … WebTACE (n = 119) or cisplatin-based TACE (n = 488) as first-line treatment of unresectable HCC between April 2024 and April 2024. With a propensity model correcting for selection bias, patients were selected from each treatment group to compare the effectiveness of drug-eluting microsphere TACE with that of cisplatin TACE. RESULTS.
WebThis retrospective single-center study included 607 patients who underwent drug-eluting microsphere (30-60 μm, loaded with doxorubicin) TACE (n = 119) or cisplatin-based TACE (n = 488) as first-line treatment of unresectable HCC between April 2024 and April 2024. With a propensity model correcting for selection bias, patients were selected ... WebCurrent adjuvant strategies include transarterial chemoembolization (TACE), hepatic artery infusion chemotherapy (HAIC), antiviral therapy, ... However, which regimen is more effective remains unclear. While one RCT showed that HAIC and low dose of cisplatin and 5-FU did not improve the OS in patients with advanced HCC ...
WebFeb 21, 2024 · Whether combined therapy using D-TACE, Gem/Cis, and PD-1 is safe. Participants will receive D-TACE (CalliSpheres with Gem 30 mg), camrelizumab (200 mg) plus gemcitabine (1000 mg/m2) and cisplatin (25 mg/m2), and 24 months follow-up. Study Design Go to Resource links provided by the National Library of Medicine
WebAug 25, 2009 · Another RCT from Hong Kong compared the use of TACE to an emulsion of cisplatin in Lipiodol and gelatin sponges and symptomatic treatment . The study showed that survival was better in patients treated with TACE (1-year survival, 57%; 2-year survival, 31%; 3-year survival, 26%) than in patients that received symptomatic treatment (1-year ... long stay hotels aurora coWebJun 25, 2013 · Cisplatin-based TACE was made as reported previously (Maataoui et al. 2005). Briefly, after exposure of the liver tumor, both the left branch of portal vein and the left branch of hepatic artery were carefully identified and prepared for further manipulation. Then cisplatin was injected via the left branch of portal vein (with the right branch ... longstay hotels beach pattayaWebConclusion: TACE using miriplatin plus cisplatin was related to a prolonged survival, with comparable adverse effects of TACE using cisplatin alone. Background: Miriplatin is a slow-release, lipophilic platinum complex, developed to produce a superior antitumor effect for hepatocellular carcinoma (HCC). However, the miriplatin suspension is ... hope the husky toyWebAug 3, 2024 · Patients with primary treatment-naive or initial recurrent advanced HCC after surgery were randomly assigned (1:1) to receive LEN plus on-demand TACE (LEN-TACE) or LEN monotherapy. LEN was initiated within 3 days after random assignment (initial dose: 12 mg once daily for patients ≥ 60 kg; 8 mg once daily for patients < 60 kg). hope theisenWebCisplatin is a platinum-based agent whose nephrotoxicity is thought related to the chloride in the cis position. Cisplatin gains entry into tubular cells via uptake by the OCT-2 system on the basolateral membrane of proximal tubular cells. • Cellular apoptosis/necrosis … hope the information helpsWebApr 18, 2024 · Purpose: To investigate clinical outcomes of drug-eluting bead transarterial chemoembolization (DEB-TACE) using HepaSpheres 20-40 µm in diameter and subsequent cisplatin-based lipiodol TACE (Cis-TACE) in patients with hepatocellular carcinoma (HCC) > … hope theisen claxtonWebJun 25, 2024 · The TACL-ECF regimen comprised transarterial infusion of epirubicin and cisplatin combined with systemic infusion of 5-FU. Of the 94 patients, 22 and 72 patients were in Barcelona Clinic Liver Cancer stages B and C, respectively; 66% patients were … long stay hotels bothell wa